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Abstract
Introduction—Although human dental pulp stem cells isolated from healthy teeth have been
extensively characterized, it is unknown whether stem cells also exist in clinically compromised
teeth with irreversible pulpitis. Here we explored whether cells retrieved from clinically
compromised dental pulp have stem cell-like properties.
Methods—Pulp cells were isolated from healthy teeth (control group) and from teeth with
clinically diagnosed irreversible pulpitis (diseased group). Cell proliferation, stem cell marker
STRO-1 expression and cell odonto-osteo-genic differentiation competence were compared.
Results—Cells from the diseased group demonstrated decreased colony formation capacity and a
slightly decreased cell proliferation rate but had similar STRO-1 expression, and exhibited a
similar percentage of positive ex vivo osteogenic induction and dentin sialophosphoprotein
expression from STRO-1-enriched pulp cells.
Conclusion—Our study provides preliminary evidence that clinically compromised dental pulp
may contain putative cells with certain stem cell properties. Further characterization of these cells
will provide insight regarding whether they could serve as a source of endogenous multipotent
cells in tissue regeneration based dental pulp therapy.
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INTRODUCTION
Pulpitis-associated pain contributes to a substantial financial and societal burden and affects
quality of life. In addition to pain and suffering, pulp infection can also cause severe, and at
times, even fatal systemic infection (1). Appropriate management of dental pulp infection
and inflammation has tremendous significance in maintaining general health. Although
immediate treatment is indispensable for a better prognosis, current endodontic therapies
typically lead to destroying or compromising pulp vitality. In adult teeth, even when the
lesion affects only part of the pulp, the entire pulp tissue is often removed (root canal
therapy). The resulting non-vital teeth often require extensive restorations, which in turn
increases the cost and the risk of complications. In primary teeth, pulpotomy treatment
involves application of formaldehyde, a toxic, mutagenic chemical that can be absorbed into
the body (2,3). Therefore, it is important to develop biocompatible treatments directed at
maintaining pulp vitality and increasing tooth longevity.
The discovery of dental pulp stem cells has important implications in both medical and
dental fields. Postnatal dental pulp stem cells (DPSCs) (4,5), stem cells from exfoliated
deciduous teeth (SHED) (6), and stem cells from the apical papilla (SCAP) (7,8), have stem
cell properties including multipotent and self-renewal capacities. They are able to
differentiate into a variety of cell types including odontoblasts in vitro (4,9) and form dentin/
pulp-like complexes in vivo (5,10). DPSCs and SCAP also have self-renewal capacity
evidenced by animal studies with human cell transplants (9,11), particularly, human SCAP
and DPSCs can regenerate a pulp-like structure de novo with established vascularity and
dentin formation when transplanted in a tooth fragment carrier (11). The discovery of
DPSCs and SCAP makes it possible to develop a biocompatible treatment based on
endogenous pulp repair or regeneration.
However, when a dental pulp is diagnosed with “irreversible pulpitis”, the available pulp
tissue is believed to be inflamed or infected. In this regard, it is unknown whether these
damaged dental pulps still contain stem cells with competent proliferation and
differentiation capacities. Answering these questions is critical for the development of
autologous stem cell based pulp therapy strategies to achieve in situ regeneration with
optimal growth factors and matrix. In this exploratory study, we hypothesized that the pulp
cells residing in pulp clinically diagnosed with “irreversible pulpitis” may still have stem




Pulp tissues were obtained from permanent teeth of patients (6–40 years of age) recruited
from outpatient clinics of the University of North Carolina at Chapel Hill (UNC-CH) School
of Dentistry under a protocol approved through the Institutional Research Board committee
of UNC-CH following consent. Healthy pulp tissues were collected from n=8 patients
undergoing orthodontic molar extraction (control group). All teeth were free of carious
lesion. Compromised dental pulps were obtained from n=8 patients with irreversible pulpitis
(diseased group) that required treatment procedures to remove pulp tissue from involved
teeth. The diagnosis of irreversible pulpitis was determined by endodontic specialists based
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on clinical assessment, including history of spontaneous pain and intense, lingering pain to
cold stimulus. The vitality of the pulp was confirmed upon access. Teeth with completely
necrotized pulp tissue were excluded.
Cell Culture
Healthy dental pulp tissue was harvested as previously described (5,12). Extracted healthy
teeth were sterilized with iodine and scaled thoroughly to remove all periodontal and
periapical tissue before drilled and sectioned in half to obtain pulp tissue. Diseased pulp
tissues were collected from pulp chambers with a sterile broach after complete exposure of
pulp chamber and transferred into sterileα-Minimum Essential Medium with 2 mM L-
glutamine (α-MEM, Gibco) penicillin and streptomycin. All pulp tissues were washed with
α-MEM with 10% fetal bovine serum (FBS, Gibco), digested and cultured as described
(5,12). Antibiotics (penicillin and streptomycin) were used in all washing, digesting buffer
and culture media to minimize bacteria contamination. Primary cells were passed to second
passage (named passage 1, P1), a portion of which was cryopreserved for later expansion.
P2–P5 cells were used in most in vitro assays. Each control and diseased pulp tissue was
processed, cultured and evaluated separately in all experiments.
Single Cell Derived Colony Formation Assay
To assess single cell derived colony formation efficiency, primary cells were seeded into 6
well plates at a live cell concentration of 0.5×105/ml as described above. Single cell derived
colonies were defined as those units with more than 50 cells. The number of colonies was
counted on the day before colonies would merge together, usually between days 13–16. For
those samples with limited colonies, the number was counted as late as 21 days of culture.
BrdU Cell Proliferation Rate Assay
Cells from each sample were seeded onto three coverslips in 6 well plates and cultured till
fully attached. Then the cells were starved in serum free medium for 24 hr before adding
back normal medium with Bromodeoxyuridine (BrdU, Roche). Proliferation was evaluated
after 24 hr according to the Zymed BrdU attaining kit instruction (Invitrogen, CA). Briefly,
BrdU incorporation was detected by a biotinylated monoclonal anti-BrdU antibody. Staining
was visualized after adding streptavidinperoxidase and diaminobenzidine (DAB). Positive
cell percentage in each coverslip was recorded by counting cells in 5 randomly selected
fields under a light microscope (Nikon ECLIPS TS100, Japan). The average BrdU positive
cells percentage of each sample was calculated and mean value from each group were
compared.
STRO-1 Expression Evaluation and STRO-1 Positive cell Purification
STRO-1 has been used as a stromal stem cell surface marker in characterizing stem cell
composition in mesenchymal stem cells (13). To investigate whether diseased dental pulp
still contains presumptive progenitor cells, we evaluated STRO-1 expression on expanded
cells by flow cytometry. Cells from each patient sample were harvested at 70% confluence,
washed, blocked in 10% FBS on ice for 1 hr at 5 × 106/ml, then incubated with anti-human
STRO-1 mouse monoclonal antibody (Chemicon) or control IgM for 1 hr on ice. After
washes with PBS, cells were incubated with Alex-488 conjugated goat anti-mouse IgG
(Invitrogen) for 30 min on ice. Cells were washed and resuspended in PBS before analysis
by a FACStar Plus flow cytometer (Becton Dickinson). The percentage of cells positive for
STRO-1 from each sample was recorded.
To obtain enriched STRO-1 positive cells, Dynabead positive isolation method was used as
previously described to obtain an enriched STRO-1-positive cell population(10,14). Briefly,
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cells were blocked with 10% FBS-PBS at 1×107/ml for 30 min on ice and incubated with
mouse anti-human STRO-1 antibody for 20 min at 4°C with rocking, then washed and
resuspended at 1×107 cells/ml in 10% FBS-PBS with 2 mM EDTA before adding anti-
mouse IgM Dynabeads (Invitrogen) with 1:4 target cell/Dynabead ratio. STRO-1 enriched
cell pellets were obtained by magnetic pull down after 20 min incubation and subsequent
washing and culture in regular medium.
Odonto-osteo-genic Differentiation
STRO-1 purified cells were seeded on 24-well plates and cultured until confluence was
achieved prior to incubation in osteogenic/odontogenic induction medium, which contains
10 mM β-glycerophosphate, 10 nM dexamethasone and 50 µg/ml L-ascorbic 2 – phosphate
in α-MEM with 10%FBS (5,15–17). Cells cultured in regular medium were used as control.
After induction for 3–4 weeks, cell cultures were fixed and assayed for mineral deposition
by Alizarin Red staining (Ricca Chemical Company, TX) (18,19). Samples with positive
mineral nodules were recorded as odonto-osteo-genic positive. Odontogenic differentiation
was also analyzed by real time quantitative reverse transcript PCR (RT-PCR) for the
expression of dentin sialophosphoprotein (DSPP) and dental matrix protein 1 (DMP1)
(20,21). Total RNA was isolated and cDNA was synthesized from 1ug of isolated RNA
using with the Omniscript RT kit (Qiagen) by random decamer primers (Applied
Biosystems/Ambion). Real time quantitative RT-PCR was performed with 1 µL synthesized
cDNA, TagMan Universal PCR Mix, and 20X on-demand primers specific for DSPP and
DMP1 genes in triplicates with ABI PRISM 7000 Detection System apparatus (Applied
Biosystem). Amplification of glyceraldehydes-3-phosphate dehydrogenase (GAPDH) from
each sample was included as internal control. The relative quantity of DSPP and DMP1
mRNA expression upon osteo-odonto-induction were calculated against GAPDH RNA
value (22).
Statistical Analysis
Wilcoxon Rank Sum test, two sample Student t-test and Fisher's exact test were used in
statistical analysis and p-value less than 0.05 was considered significant.
RESULTS
Eight subjects were recruited in each of the control and diseased groups. There was no
significant difference in the average age between two groups. All teeth in the diseased group
had post-caries irreversible pulpitis confirmed by positive cold tests and bleeding during
debridement, with history of spontaneous pain that ranged from 1 day to two months
(average duration of 25 days).
Cells from Pulp with Irreversible Pulpitis (Diseased Group) Formed Single Cell Derived
Colonies In Vitro, with Lower Frequencies Than Healthy Controls
Almost all single cell-derived colonies emerged at day 5 to 6 in the control group and at day
7 to 8 in the diseased group. One sample in the diseased group did not have any cell growth
and another sample did not form colonies despite having fibroblast-like cell growth. Cells
within each colony showed typical fibroblast-like morphology, with colony or cell
morphology being similar between the control and diseased groups (Fig. 1A). However, the
frequency of single cell derived colony formation in diseased group (4.7±5.9 per plate) was
significantly lower than that of control group (36.0±26.1, p<0.05) (Figure 1B). This
indicates that stem cells containing proliferative capacity still exist in compromised pulp
tissue; however, the number of those cells is significantly decreased.
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Cells from Diseased Group Exhibited Slightly Lower Cell Proliferation Rate Than Control
Group
The average percentage of BrdU positive cells in the control group (84±9%, n=7) was
significantly higher than that of the diseased group (58±25%, n=6, p<0.05) (Figure 1C).
Direct cell counting (data not shown) also demonstrated that diseased pulp cells exhibit a
lower proliferation potential than healthy pulp cells in expanded passages.
Cells from Diseased Group Exhibits Comparable STRO-1 Expression as That From Control
Group
Expanded cells from the diseased group had a similar percentage of STRO-1 positive
population (13.9±6.2%) compared to the control group (11.1±5.7) (Figure 2). This suggests
that comparable percentage of presumptive progenitor cells still exist even when the dental
pulp tissue is extremely compromised.
Differentiation Competence of Ex Vivo Expanded DPSCs In Vitro
To investigate whether those STRO-1 positive cells from the diseased group still have the
ability to differentiate into dentin-forming cells, we evaluated their in vitro odontogenic
differentiation potential. Most samples of both groups (5 out of 7 samples in the control
group and 5 out of 6 samples in the diseased group) had positive mineralization staining,
indicating competent odonto-osteo-genic differentiation of STRO-1 positive cell population
in both groups (Figure 3A). There was no significant difference in the percentage of samples
exhibiting mineral deposition between control and diseased group. However, variations in
the quantity of mineralization were noted, especially in the diseased group (data not shown).
qRT-PCR showed no statistically significant difference in DSPP gene expression (Figure
3B). DMP1 gene expression was not detected in either group.
DISCUSSION
DPSCs are able to form dentin and a pulp-like complex, making them multipotent, and an
excellent source for dental pulp tissue regeneration. However, when patients have a
toothache with irreversible pulpitis, the available pulp is usually in an inflamed condition.
This clinically compromised dental pulp was long believed to have no value and was
therefore discarded during treatment. Our study shows that diseased pulp contains viable
cells with the potential for ex vivo expansion and proliferation, with a similar percentage of
STRO-1 positive cells and ex vivo odonto-osteo-genic differentiation capacity, suggesting
that even clinically compromised dental pulp tissues may have putative stem cells that could
be used in endogenous pulp regeneration. In addition, our results also indicate that the
usually discarded pulp tissue during endodontic therapy may be used in research on stem
cell therapy for other diseases.
We observed low frequency of single cell derived colony formation in primary culture in the
diseased group. This is likely due to the decreased cell proliferation rate and stem cell
number. In addition, cell component may change during inflammation due to increased
vascular permeability. There is increased inflammatory and blood cell infiltration in the pulp
tissue which can lead to alteration of stem cell ratio in the primary cell culture. It is not clear
why cells from two diseased samples did not form colony in primary culture given the fact
that patients’ ages and clinical presentations were similar to other samples in the diseased
group. Although statistically significant, proliferation rate of diseased pulp cells was just
slightly lower than the control in expanded passages, indicating that proliferation potential is
slightly compromised, but still robust. Interleukin-1 beta, an inflammatory mediator, has
inhibitory effects on pulpal fibroblastic proliferation through the induction of prostaglandin
E2 synthesis (23). Therefore, inflammatory mediators present in the diseased pulp may play
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an important role in altering the proliferation and colony formation rate in the stem cells.
STRO-1 expression levels in our study are comparable to similar study (6). Interestingly,
diseased pulp exhibited a slightly higher STRO-1 expression although it is not statistically
significant.
The discrepancy between low colony formation frequencies, slightly compromised
proliferation potential and similar STRO-1 expression in diseased cells indicating that
inflammation might affect stem cell proliferation and/or recruitment. Inflammation derived
stromal cell-derived factor 1 alpha (SDF-1α) and its receptor CXC chemokine receptor 4
(CXCR4) are known that can direct migration of stem cells to injury site in central nervous
system (24) or myocardium (25). Inflamed pulp expresses high level of SDF-1/CXCR4
(26,27), indicating that inflammation may also play a role in stem cell recruitment in dental
pulp. This needs further detailed basic cell biology research to confirm.
Upon examining STRO-1 purified pulp cells, we found no difference in odonto-
differentiation between the control and diseased groups via a qualitative test evaluating
positive rate in each group. Due to a limited sample size and variation in the extent of pulpal
inflammation in the diseased group, it was difficult to compare mineralization activities
quantitatively. However, we did observe that the diseased group had a higher variability in
the degree of mineralization. These variations may result from various degrees of
inflammation, patient age and tooth developmental stage, etc. within the diseased group.
How inflammation affects progenitor cell differentiation capacity is not clearly understood;
however, mild inflammation was believed to enhance odontoblastic and osteoblastic
differentiation and matrix formation, while severe inflammation was believed to induce
apoptosis of these stem cells (28). With information gained from current study, future study
using established cell culture and well-controlled inflammation intervention (like LPS, TNF-
alpha, etc) should be done to evaluate how inflammation affects stem cell osteo-genic
differentiation potential qauntatively.
We could not detect DMP1 gene expression while DSPP expression is robust. We believe
this is probably due to the timing that we evaluate gene expression after osteoinduction for
3–4 weeks when mineral nodules were formed. DMP1 expression seems to be more
temporal sensitive (29,30). DMP1 and DSPP both are expressed in young odontoblasts, but
at later stage after appearance of mineral, DMP1 expression is greatly decreased while
DSPP continue to have high-level expression (30). Therefore, it is very likely DMP1
expression was greatly decreased at our evaluation point.
This study is an exploratory study aiming to determine if cells from diseased dental pulp
have stem cell-like properties and the potential to differentiate into dentin-forming
functional pulp cells. There is limited information regarding whether clinically compromised
teeth contain functional DPSCs. Our findings are consistent with a recent study showing that
teeth with complicated crown fracture also have functional DPSCs (31). Future studies
incorporating in vitro and in vivo multilineage differentiation assays including odontogensis
and angiogenesis are indicated to fully characterize these cells. Studies with larger sample
size are necessary to correlate the degree of inflammation and clinical presentation with cell
proliferation and/or differentiation competence. This will help set clinical guidelines to
predict whether a given diseased pulp has stem cells that retain the potential to proliferate
and differentiate. Additionally, determination of appropriate growth factors and matrix to
facilitate regeneration is required to achieve in situ endogenous stem cell based regeneration.
In conclusion, our exploratory study suggests the existence of functional putative stem cells
in clinically compromised dental pulp with irreversible pulpitis. Further characterization of
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these cells will provide insight regarding whether they could serve as a source of
endogenous multipotent cells in tissue regeneration based dental pulp therapy.
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Figure 1. Single cell derived colony formation in primary culture and cell proliferation in
expanded cultures from both control and diseased groups
A: Colony morphology is similar in control and diseased groups. Pictures show part of a
colony, taken between days 10–14 (objective 10×). B. Colony formation frequency was
defined as the number of units with more than 50 cells. Cultures were fixed with 10%
buffered formalin phosphate between days 10 to 21 and then stained with 0.1% crystal
violet. Each experiment was performed in triplicates. Wilcoxon Rank Sum test, p=0.021;
ratio of means (i.e., fold change) 90% CI (3.1, 18.8). C. The average percentage of BrdU
positive cells in each group was calculated. BrdU was incorporated into proliferating cells
and then detected by a monoclonal anti-BrdU. The percentage of positive cells of each
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sample was recorded by counting 5 randomized fields (objective 10× or 20×) and the mean
percentage of positive cells was compared. Pictures are representative examples from each
group taken at 10×. Error bars represent standard deviation. Wilcoxon Rank Sum test,
p=0.036; fold change 90% CI (1.04, 2.01).
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Figure 2. Diseased pulp cells exhibit similar STRO-1 expression to that of control cells
Cell suspension from expanded culture was collected and pre-incubated with mouse anti-
human STRO-1 monoclonal antibody followed by incubation with Alexa-488-labelled goat
anti-mouse IgG, and then evaluated by flow cytometery. A. Histogram of a sample from
diseased group at FL-1 channel for Alexa-488 fluorescence intensity. B. Percentages of
STRO-1 positive cells were documented in each sample with the negative control set at 5%
and mean value from each group was calculated. Error bars represent standard deviation.
Wilcoxon Rank Sum test, p=0.387, 90% CI (0.51, 1.26).
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Figure 3. Osteogenic differentiation potential of STRO-1 positive pulp cells from control and
diseased pulp tissue
A. Representative examples of most positive alizarin red-S stained culture 21 days after
ostegenic induction in each group, and qualitative description of osteo-odonto-genic
differentiation activity. Fisher's exact test, p=1.00. B. Real time PCR analysis of DSPP gene
expression, maker for odontoblast differentiation, compared to expression of GAPDH
indicated as box plots (Q1-the first quartile, Q3-the third quartile, Min-minimum level, Max-
maximum level). Adjusted t-test based upon Kenward-Roger degrees of freedom correction
(32) within a linear mixed models framework to account for multiple batches per subject and
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repeat experiments within batch (or same mRNA sample); total of 35 replicates comparing
five control versus four diseased subjects, p=0.500.
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